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F racture complications, particularly long bone fracture nonunions, represent a signifi cant challenge to the orthopedic surgeon and carry an inherent risk of morbidity to the patient. [1] [2] [3] Although approximately 90% of osseous injuries heal without impairment, the prevalence of nonunion has been recorded in as many as 10% of fractures and is increasingly associated with open and extensive soft tissue injuries. [4] [5] [6] The incidence of long bone fracture nonunion varies, with rates between 1% and 20% reported for humerus, femur, and tibia fractures. 1 However, up to 23.1% of all fracture patients require reoperation for failed or inappropriate fracture union. 4 Despite the success of recent advancements in fracture management, the incidence and associated complications of nonunion procedures are disconcerting and remain concerns for the treating surgeon.
Although not all nonunions are the same, the general principal behind an optimal outcome is restoration of the limb to as complete of function as possible. 7 The gold standards of long bone fracture nonunion management are fi brous debridement, stable fracture fi xation, augmentation of the nonunion site with autologous iliac crest bone graft when necessary, and adequate soft tissue coverage. 2, 5, 8 Mechanical stability is provided through internal fi xation, whereas biological enhancement of the osseous environment via autologous graft affords in-growth of bone material. The reported morbidity associated with such a procedure is a signifi cant consideration for both the patient and the surgeon. The incidence of major complications associated with bone graft harvesting is reported in approximately 10% of patients, with minor complications occurring in 40%. 5, 9, 10 Chronic pain at the donor site is documented in nearly 20% of iliac crest harvest procedures. 11 Investigations to determine an equally suitable and less morbid alternative to autologous iliac crest bone graft to stimulate fracture healing have resulted in the development of several bone graft substitutes. [12] [13] [14] Certain orthobiologics, in particular recombinant human bone morphogenetic protein-2 (rhBMP-2), are an appealing option to autologous bone graft and provide a nonunion environment with molecular properties that are necessary for appropriate bone union. 4, 15 The use of rhBMP-2 as an adjunct in the treatment of fracture nonunions is becoming a signifi cant area of interest to the orthopedic trauma community. 4, 16 To our knowledge, little documentation exists in the literature evaluating rhBMP-2 to autologous bone graft for use in nonunion revision. The purpose of this clinical study was to assess the effi cacy of rhBMP-2 as compared to harvested autologous iliac crest bone graft in the treatment of established long bone fracture nonunions.
MATERIALS AND METHODS
Following Institutional Review Board approval, data from patients older than 18 years who were treated at a universitybased Level I trauma center from January 2002 to June 2004 with the diagnosis of a long bone nonunion were retrospectively reviewed. Long bone fractures included for evaluation were femur, tibia, and humerus fractures, because these represent the most common nonunion following long bone fracture (Table 1) . 1 Patient demographic, medical history, initial fracture treatment, subsequent nonunion treatment, and operative and follow-up data were entered into a database.
A diagnosis of nonunion was identifi ed in the patient medical record and crossreferenced with radiographic data. Clinical evidence of a nonunion was determined by documented pain and motion at the fracture site. Images were reviewed by the 3 senior authors (M.A.T., P.J.K., W.T.O.), all boardcertifi ed and fellowship-trained orthopedic trauma surgeons, to determine study inclusion. Nonunion was determined by lack of radiographic evidence of bone bridging on 3 of 4 cortices 6 months after injury or a fracture that had not displayed progression of healing over a 3-month period. [17] [18] [19] When there was disagreement between clinical and radiographic data, a computed tomography (CT) scan was reviewed to confi rm the diagnosis. All nonunions included in the fi nal analysis achieved simultaneous clinical and radiographic criteria of a nonunion. No patients were included in analysis if they were actively being treated for an infection at the fracture site at the time of nonunion revision.
SURGICAL TECHNIQUE
Patients were selected to receive either iliac crest autograft or an orthobiologic synthetic bone substitute based on the attending surgeon's preference. Surgeons tended to use only 1 method of grafting in their practice, and the basic principles of nonunion treatment were used by all involved surgeons. These include (1) determining whether an infectious process is present with appropriate preoperative laboratories (ie, white blood cell count [WBC] , erythrocyte sedimentation rate [ESR] , and C-reactive protein [CRP] ) and intraoperative cultures; (2) debridement of fi brous tissue that may impede osseous bridging between bone ends; (3) provision of appropriate mechanical stability for osseous bridging and remodeling; (4) addi- tion of osteogenic material to the area of the nonunion; and (5) assuring adequate soft tissue coverage. 7, 19 Patients were excluded from data analysis if purulence was visible at the nonunion site and microbiologic data demonstrated an infection because this represented an active infectious process. Those patients who had been previously treated for an infected nonunion with operative debridement and completion of antibiotic medication and had demonstrated resolution of infection by laboratory markers (ie, normal CRP, ESR, WBC, and intraoperative gram stain) prior to nonunion treatment with bone graft were included in study analysis. These patients were documented as having a previous nonunion infection. Immediately following the operative procedure to correct the nonunion, all patients included in the study received an appropriate dosage and duration of postoperative antibiotic prophylaxis.
Autologous Bone Harvesting
Harvesting of autologous iliac crest bone graft was conducted in the standard surgical fashion. 20 The choice of an anterior or posterior approach to the ilium was determined by the location of the fracture nonunion and the subsequent operative plan that most appropriately accessed the nonunion site. Defects in the ilium were fi lled with Gelfoam (Pfi zer, New York, New York) containing bupivicaine, thrombin, and epinephrine. The subcutaneous tissue was approximated in layers and additional bupivicaine was injected subcutaneously. The amount of harvested graft was not uniformly recorded and therefore was not obtainable from either the offi cial operative record or the attending surgeon's operative dictation. Therefore, total amount of graft harvested for each patient in the autograft cohort was not available for study analysis.
Preparation of rhBMP-2 and Allograft
Patients who were treated with a synthetic orthobiologic graft received a combination of rhBMP-2 on an absorbable collagen sponge (Medtronic Sofamor Danek, Memphis, Tennessee) that was applied with allograft cancellous bone chips. The device was prepared with 12 mg of rhBMP-2 on a 7.62ϫ10.16-cm absorbable collagen sponge. The administration of an inert carrier substance in the form of an absorbable collagen sponge is necessary to (1) maintain a critical threshold concentration of rh-BMP-2 at the nonunion site; (2) provide a matrix for osteoprogenitor cell infi ltration; and (3) contain the rhBMP-2 at a localized site and prevent heterotopic bone formation. 21 The rhBMP-2 was reconstituted under appropriate conditions in the operating room with 8 mL of sterile water, resulting in the concentration of 1.50 mg/mL, and was applied to the carrier sponge.
Freeze-dried, cancellous allograft bone chips were provided in pre-packaged containers. An amount necessary to completely fi ll the bone defect was applied to the fracture gap, as described in further detail below. Cancellous allograft provides a scaffold on which bone regeneration consolidates a nonunion defect. 4, 16, 22 The product of this mixture of allograft and rhBMP-2/absorbable collagen sponge has been demonstrated to be effi cacious in the treatment of open tibial fractures and tibial fractures with cortical defects 14 ; however, its application in nonunion procedures is undetermined, and current use for this indication is considered off-label.
Nonunion Revision
Following a standard operative approach and exposure down to osseous structures, fi brous tissue at the fracture site was debrided with a burr until healthy and viable bone was visualized. Stabilization was provided by either open reduction internal fi xation (ORIF) with a plate or with an intramedullary nail. The choice of fi xation method was at the discretion of the treating surgeon. In general, metaphyseal nonunions were treated with plate fi xation, and diaphyseal nonunions were treated with intramedullary nail stabilization. Either the synthetic orthobiologic device combined with allograft cancellous bone chips or autologous bone graft was applied to the nonunion site. Each graft was used exclusively, and no patient received a combination of treatment methods.
For patients who received autologous iliac crest graft, the harvested bone was implanted within the fracture defect to completely fi ll the void and cover the exposed bone edges both proximally and distally. Patients in the synthetic bone graft group received cancellous bone chips in a similar manner, circumferentially fi lling the fracture nonunion defect and covering the proximal and distal bone surfaces. The rh-BMP-2/absorbable collagen sponge device was then applied to the allograft implant. When plate fi xation was used, the grafting technique was applied prior to stabilization. For patients who received an intramedullary nail, application of the graft was performed after fi nal seating of the nail. Appropriate soft tissue coverage was provided prior to complete wound closure, and any additional procedures to afford a soft tissue muscular fl ap were recorded from the operative record for fi nal analysis. Operative time and estimated blood loss were recorded from the offi cial intraoperative record, and hospital length of stay was calculated from the medical record.
Outcome Assessment
Standard postoperative procedures were followed. Immediate postoperative visits occurred at 1 to 2 weeks for assessment of wound healing. Further follow-up evaluations were documented, and data relevant to the physical examination of the affected extremity, including infectious complications, radiographic images, and need for further procedures to address the nonunion site, were noted. Postoperative infection was considered if gross drainage was noted from the nonunion surgical site wound and treated with oral antibiotics or when the wound necessitated operative debridement. Positive microbiologic confi rmation by culture from the nonunion site was treated with species-specifi c intravenous antibiot-ics administration for 6 weeks in conjunction with infectious disease consultation.
All nonunion operations were determined to have adequate stable fi xation. Adequacy of internal fi xation was judged by the 3 senior authors, who retrospectively reviewed the immediate postoperative radiographs. Union was established by concomitant clinical and radiographic evidence. Anteroposterior (AP) and lateral radiographs were examined by the senior authors, and union was determined by majority agreement of osseous bridging or disappearance of fracture lines on at least 3 of 4 cortical surfaces. These radiographs were cross-referenced with the physical examination record to demonstrate that the patient was weight bearing as tolerated with no pain at the fracture site. Union was established when both clinical and radiographic evidence were in agreement. 23 Fractures that did not demonstrate consolidation on both clinical and radiographic examination at the most recent clinic visit were documented as a failed union.
Statistical Analysis
Descriptive statistics were used to evaluate the study population demographics and the perioperative outcomes of estimated blood loss, operative time, and hospital length of stay relative to the bone graft treatment group. Bivariate statistical analysis was conducted to determine the associations of patient demographic factors, initial fracture treatment method, fracture nonunion characteristics, perioperative infections, and type of bone graft on the outcome of fracture nonunion healing. Chi-square test and Fisher's exact test were used for dichotomous variables, such as sex, diabetes mellitus, nicotine use, osteoporosis, nonunion type, nonunion location, nonunion fi xation method, bone defect у2 cm, perioperative infections, and bone graft type. Nonparametric continuous variables were evaluated by the Kruskal-Wallis test.
Variables are reported as meanϮstan-dard deviation (SD) or as raw percentages where applicable. The primary outcome of nonunion healing is presented as an odds ratio (OR) with 95% confi dence interval (CI) for ultimate fracture consolidation when evaluating the 2 graft types. Statistically signifi cant variables, in addition to the clinically signifi cant variables of age and female sex, 7, 19, 24 were then inserted into a multivariable logistic regression model to determine the effect of confounding variables on bone graft type for the primary outcome. Results are reported as OR with 95% CIs. Statistical signifi cance was considered for a P value Ͻ.05. Analysis was conducted with STATA Statistics/Data Analysis 11.0 (College Station, Texas) software. (Table 3) . Initial fracture treatment was nonoperative in 7 (7.5%) of 93 patients, external fi xation in 5 (5.4%) of 93, ORIF in 33 (35.5%) of 93, and intramedullary nail in 48 (51.6%) of 93. There was no difference in initial fracture treatment and nonunion healing. Nonunion location was diaphyseal in 55 (59.1%) of 93 patients and metaphyseal-diaphyseal in 38 (40.9%) of 93. There was no difference in osseous consolidation with regard to diaphyseal and metaphyseal-diaphyseal nonunion location and the type of nonunion had no association with ultimate resolution. The average osseous defect size was 1.3Ϯ1.2 cm (range, 0-7 cm). There was no difference in healing for bone defects у2 cm. Previous infection at the nonunion site demonstrated no association with fracture consolidation (Table 4) .
RESULTS

Complete
Internal fi xation during the nonunion revision procedure consisted of ORIF in 51 (54.8%) of 93 patients and intramedullary nail in 42 (45.2%) of 93 patients. There was a signifi cant difference in whether a nonunion healed when compared by fi xation methods (Table 4) . There was no difference in the incidence of postoperative infections between autologous iliac crest bone graft (12/ There was no difference in mean hospital length of stay between the autologous bone graft (3.8Ϯ2.5 days) and rhBMP-2/ absorbable collagen sponge (3.2Ϯ2.6 days) (Pϭ.16) treatment groups.
Logistic regression revealed no signifi cant difference in autologous iliac crest bone graft (OR, 2.64; 95% CI, 0.83-8.43) or rhBMP-2/absorbable collagen sponge (OR, 0.38; 95% CI, 0.12-1.20) on the effect of long bone union. After adjusting for potential confounding variables of age, female sex, and nonunion fracture stabilization with ORIF and plate fi xation, multivariable logistic regression demonstrated no signifi cant difference in the effect of bone graft type on the primary outcome (Table 5 ). Further analysis revealed that after inclusion in the multivariable regression A post-hoc power analysis was performed to determine the power of our study. Regarding the primary objective of determining a signifi cant difference in the rate of nonunion resolution between autologous bone graft and rhBMP/absorbable collagen sponge, our results are reported with a 40% power. A sample size of 124 would have been required to detect a true difference.
DISCUSSION
Complications of fracture healing, specifi cally fracture nonunion, are signifi cant concerns for the orthopedic surgeon. 2, 6, 25 Despite the improvements in surgical technique and orthopedic implants, recent literature has noted that standard treatment of certain long bone fractures results in higher rates of nonunion than what was previously believed. 26 Increased rates of complex, high-energy traumatic fractures have been reported, and subsequently the degree to which these complex injuries are aggressively treated has also increased. 3, 19 Furthermore, the resources available to stimulate consolidation of a nonunion are valuable tools in fracture management.
Potential causes of nonunion are excess motion, inadequate vascularity, signifi cant fracture gap, and infection. 2, 7 Treatment of a fracture nonunion requires attention to the principles of bone regeneration and healing in conjunction with an understanding of the local pathologic process. Multiple factors are involved in the sequence of events that results in normal fracture union. 19, 27, 28 Maintaining or restoring these factors is essential to successful fracture management. 7 Osteogenesis, osteoinduction, and osteoconduction are the principal elements involved in bone graft design and selection for nonunion management. 29 Osteogenesis describes the ability of living cells to survive transplantation, proliferate, and differentiate into viable osteocytes. 30 Osteoinduction is characterized by the stimulation and activation of host cells from surrounding tissue to differentiate into bone-forming osteoblasts. 31 Osteoconduction is the ability to create and orient the surrounding environment into a stable bone scaffold or matrix capable of supporting the mature osteocytes. 16 Each type of bone graft and bone graft substitute maintains a portion of these essential elements, and the ideal graft incorporates all properties of osteogenesis, osteoinduction, and osteoconduction into a healing osseous environment. 16, 22, 29 Autologous cancellous bone is the gold standard by which bone graft is measured and is the only graft capable of providing all 3 elements of bone regeneration. 8, 22, 29 The historical success of autologous grafting is not without complications and morbidity because approximately 25% of patients treated with autologous graft are noted to have prolonged pain at the harvest site, seroma, hematoma, infection, or neurologic symptoms (eg, meralgia paresthetica). [9] [10] [11] The amount of graft is also limited in quantity and quality, especially in certain patient populations (eg, patients of advanced age). 5, 22, 29 Therefore, investigations to provide a less morbid yet equally effective alternative have focused on a group of proteins, normally found in bone, that have been synthetically derived and are easily and practically applied to the nonunion site. 31 Since their discovery by Urist 32 in 1965, bone morphogenetic proteins have been described by the inherent property of osteoinductivity that affects surrounding bone cells and tissues to actively participate in the fracture repair process. 15, 16, 29, 31 The ability to attract and stimulate osteoprogenitor cells to differentiate into chondrocytes and osteoblasts and participate in bone formation is a defi ning characteristic of this synthetic bone substitute. Although BMP lacks the element of osteoconductivity present in autologous bone graft, certain inert, allographic materials have been used in conjunction with BMP to provide the necessary biologic scaffold on which bone formation is integrated. 14, 32 The application of this device has been shown to be a safe and effective alternative to autologous graft in certain clinical settings, and numerous studies have documented the effi cacy of this bone substitute for these indications. 4, [33] [34] [35] [36] Our study is unique in that we compare an alternative to the gold standard treatment of autologous iliac crest bone graft for long bone fracture nonunions. Of further clinical importance is that patients who received rhBMP-2/absorbable collagen sponge had signifi cantly shorter operative times and less intraoperative blood loss. These fi ndings are in agreement with a prior study that noted a reduction in certain perioperative outcomes in patients who receive synthetic bone graft. 37 Previous literature in acute fracture care describes the osteoinductive properties of rhBMP-2 but that the effi cacy is not superior to that of autologous bone graft.
14,31 Our data revealed that autologous graft yielded a higher rate of bone union when compared to the synthetic graft; however, this failed to achieve statistical signifi cance.
The context in which our evaluation of rhBMP-2 and autologous bone graft was performed should not be misunderstood. The lack of a statistically signifi cance difference between rhBMP-2 and autologous bone graft on the primary outcome must be interpreted with caution. This was a retrospective study with all the inherent weaknesses. Limitations include the use of surgeon's preference in grafting method which could potentially introduce a source of bias. Also, the amount of autologous graft harvested was not uniformly recorded. Whereas the rhBMP dose was identical, the iliac crest graft group most likely did not receive uniform amounts. This could have served as a potential confounder to our results. Furthermore, this is a small sample size of a heterogenous population of long bones with the potential for ␤-error. These fracture nonunions represent challenging complications from relatively common injuries; however, it was impossible to control for subtle differences that are inherent to the treatment of each fracture type. Future studies would require multi-center organization and randomization to appropriately control for preexisting factors and achieve clinically signifi cant power.
CONCLUSION
This study suggests that rhBMP-2 may provide a suitable alternative to autologous iliac bone graft and may be considered as part of the orthopedic surgeon's treatment options. The ability to treat highly complex fractures will continue to evolve and subsequently provide an opportunity to manage potential complications. The morbidity associated with failure of fracture union extends beyond surgeon and patient and is a serious concern for all parties involved in fracture care. We acknowledge that autologous iliac crest bone graft remains the gold standard against which all bone graft materials are measured. However, evidence from our study suggests rhBMP might offer potential advantages over the gold standard, such as reduced operative time and intraoperative blood loss. Clinical application of rhBMP is a rapidly expanding focus of orthopedic research and requires appropriate scientifi c investigation. Defi nitive judgment cannot be extrapolated until more rigorous, large, randomized clinical studies provide critical evaluation and evidence for the effi cacy and safety of orthobiologic materials in the management of long bone nonunion.
